279 related articles for article (PubMed ID: 29698670)
21. Cell secretome based approaches in Parkinson's disease regenerative medicine.
Marques CR; Marote A; Mendes-Pinheiro B; Teixeira FG; Salgado AJ
Expert Opin Biol Ther; 2018 Dec; 18(12):1235-1245. PubMed ID: 30422014
[TBL] [Abstract][Full Text] [Related]
22. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses.
Costa LA; Eiro N; Fraile M; Gonzalez LO; Saá J; Garcia-Portabella P; Vega B; Schneider J; Vizoso FJ
Cell Mol Life Sci; 2021 Jan; 78(2):447-467. PubMed ID: 32699947
[TBL] [Abstract][Full Text] [Related]
23. Pericytes, mesenchymal stem cells and their contributions to tissue repair.
Wong SP; Rowley JE; Redpath AN; Tilman JD; Fellous TG; Johnson JR
Pharmacol Ther; 2015 Jul; 151():107-20. PubMed ID: 25827580
[TBL] [Abstract][Full Text] [Related]
24. Harnessing the mesenchymal stem cell secretome for regenerative urology.
Sun DZ; Abelson B; Babbar P; Damaser MS
Nat Rev Urol; 2019 Jun; 16(6):363-375. PubMed ID: 30923338
[TBL] [Abstract][Full Text] [Related]
25. Emerging Role of Mesenchymal Stem Cell-derived Exosomes in Regenerative Medicine.
Zhao T; Sun F; Liu J; Ding T; She J; Mao F; Xu W; Qian H; Yan Y
Curr Stem Cell Res Ther; 2019; 14(6):482-494. PubMed ID: 30819086
[TBL] [Abstract][Full Text] [Related]
26. Neural differentiation of rat aorta pericyte cells.
Montiel-Eulefi E; Nery AA; Rodrigues LC; Sánchez R; Romero F; Ulrich H
Cytometry A; 2012 Jan; 81(1):65-71. PubMed ID: 21990144
[TBL] [Abstract][Full Text] [Related]
27. Pericytes in Tissue Engineering.
Çelebi-Saltik B
Adv Exp Med Biol; 2018; 1109():125-137. PubMed ID: 30523594
[TBL] [Abstract][Full Text] [Related]
28. Stem cells as drug delivery methods: application of stem cell secretome for regeneration.
Tran C; Damaser MS
Adv Drug Deliv Rev; 2015 Mar; 82-83():1-11. PubMed ID: 25451858
[TBL] [Abstract][Full Text] [Related]
29. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?
Mocchi M; Dotti S; Bue MD; Villa R; Bari E; Perteghella S; Torre ML; Grolli S
Cells; 2020 Jun; 9(6):. PubMed ID: 32545382
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.
Vizoso FJ; Eiro N; Cid S; Schneider J; Perez-Fernandez R
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841158
[TBL] [Abstract][Full Text] [Related]
31. Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery.
Ellison-Hughes GM; Madeddu P
Pharmacol Ther; 2017 Mar; 171():1-12. PubMed ID: 27916652
[TBL] [Abstract][Full Text] [Related]
32. Exosomes as Part of the Human Adipose-Derived Stem Cells Secretome- Opening New Perspectives for Cell-Free Regenerative Applications.
Dinescu S; Dobranici A; Tecucianu R; Selaru A; Balahura R; Ignat S; Costache M
Adv Exp Med Biol; 2021; 1312():139-163. PubMed ID: 32986128
[TBL] [Abstract][Full Text] [Related]
33. The stem cell secretome and its role in brain repair.
Drago D; Cossetti C; Iraci N; Gaude E; Musco G; Bachi A; Pluchino S
Biochimie; 2013 Dec; 95(12):2271-85. PubMed ID: 23827856
[TBL] [Abstract][Full Text] [Related]
34. Blood/plasma secretome and microvesicles.
Inal JM; Kosgodage U; Azam S; Stratton D; Antwi-Baffour S; Lange S
Biochim Biophys Acta; 2013 Nov; 1834(11):2317-25. PubMed ID: 23590876
[TBL] [Abstract][Full Text] [Related]
35. Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration.
Lu Y; Mai Z; Cui L; Zhao X
Stem Cell Res Ther; 2023 Mar; 14(1):55. PubMed ID: 36978165
[TBL] [Abstract][Full Text] [Related]
36. Disagreements in the therapeutic use of mesenchymal stem cell-derived secretome.
Sipos F; Műzes G
World J Stem Cells; 2022 Jun; 14(6):365-371. PubMed ID: 35949398
[TBL] [Abstract][Full Text] [Related]
37. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome.
Jahandideh S; Maghsood F; Ghahhari NM; Lotfinia M; Mohammadi M; Johari B; Kadivar M
Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of the secretome of human bone marrow-derived mesenchymal stem cells primed by pro-inflammatory cytokines.
Maffioli E; Nonnis S; Angioni R; Santagata F; Calì B; Zanotti L; Negri A; Viola A; Tedeschi G
J Proteomics; 2017 Aug; 166():115-126. PubMed ID: 28739509
[TBL] [Abstract][Full Text] [Related]
39. Secretome within the bone marrow microenvironment: A basis for mesenchymal stem cell treatment and role in cancer dormancy.
Eltoukhy HS; Sinha G; Moore CA; Gergues M; Rameshwar P
Biochimie; 2018 Dec; 155():92-103. PubMed ID: 29859990
[TBL] [Abstract][Full Text] [Related]
40. Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products.
Laggner M; Gugerell A; Bachmann C; Hofbauer H; Vorstandlechner V; Seibold M; Gouya Lechner G; Peterbauer A; Madlener S; Demyanets S; Sorgenfrey D; Ostler T; Erb M; Mildner M; Ankersmit HJ
Stem Cell Res Ther; 2020 Jan; 11(1):9. PubMed ID: 31900195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
